About

About Epistem Ltd Epistem's oncology team has a solid reputation and extensive experience in guiding therapeutic agents through various stages, including early-stage in vitro proof of concept testing, in vivo efficacy models, and the quantification of target engagement via biomarkers to support clinical studies. Our services are available individually or as part of a comprehensive integrated package. Our analytical capabilities include histology & IHC, pharmacogenomics, advanced imaging and analysis, as well as flow cytometry & cytokine profiling, providing clients with practical and effective support for their research and development needs. We also offer additional models, such as dermatological (in vitro and in vivo), wound healing (in vitro and in vivo), inflammatory diseases (IBD), and organoid models for toxicity testing across four different species.